ReviewCurrent pharmaceutical design2014

Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity.

Paul R Albert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.